Ameriprise’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Ameriprise’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-167,216	Closed	-$2.83M	–	4015
2014 Q4	$2.83M	Sell	167,216 -1,042,945	-86%	-$14.7M	﹤0.01%	2385
2014 Q3	$14.4M	Buy	1,210,161 +1,207,246	+41,415%	+$8.24M	0.01%	1175
2014 Q2	$16K	Buy	2,915 +130	+5%	+$599	﹤0.01%	4455
2014 Q1	$11K	Buy	2,785 +2,375	+579%	+$9.05K	﹤0.01%	4507
2013 Q4	$1K	Sell	410 -9,045	-96%	-$37.4K	﹤0.01%	5065
2013 Q3	$40K	Hold	9,455	–	–	﹤0.01%	3958
2013 Q2	$44K	Buy	+9,455	New	+$32.5K	﹤0.01%	3793

Ameriprise's AVNR Position: Q1 2015 in Review

Ameriprise sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 167,216 shares — an estimated $2.83M sold.

Ameriprise first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $14.4M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Ameriprise reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Ameriprise sold 167,216 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $2.83M.
Ameriprise first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
Ameriprise's AVANIR PHARMACEUTICALS, INC CL A position peaked at $14.4M in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Ameriprise's 13F filing for Q1 2015, filed 14 May 2015.